ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide"
June 30, 2021Hanmi Pharmaceutical recently announced that its new, long-acting diabetes biologic drug, efpeglenatide, was shown to significantly reduce incidences of major adverse cardiovascular events (MACE) and kidney disease in the results of its global ... -
Syntekabio, Hanmi to Co-Develop COVID-19 Treatments Using Drug Repurposing Technologies
January 27, 2021Syntekabio and Hanmi Science have entered into a strategic collaboration to co-develop breakthrough COVID-19 treatments using drug repositioning technologies. -
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
January 19, 2021Hanmi Pharmaceutical Co., Ltd. plans to create a global R&D achievement based on innovations of inflammation–fibrosis treatment, Triple-acting new drug for NASH (non-alcoholic steatohepatitis) treatment as well as various other innovations in ... -
Top Korean pharma companies increase their R&D spending in H1
August 17, 2017Regulatory filings of 15 listed pharmaceutical firms showed 10 having upped their R&D expenditures in the January-June period from a year ago
Pharma Sources Insight January 2025
